BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu G, Wang YM, Ying MM, Chen SD, Li ZR, Ma HL, Zheng MH, Wu J, Ding C. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clin Mol Hepatol 2021;27:329-45. [PMID: 33465844 DOI: 10.3350/cmh.2020.0261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chawla H, Bhosale V, Misra R, Sonkar SK, Kohli N, Jamal N, Vimal SR, Dangi B, Durgapal K, Singh S, Negi MPS, Ghatak A. Lipocalin-2 levels increase in plasma of non-alcoholic fatty liver disease patients with metabolic syndrome. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-022-01058-3] [Reference Citation Analysis]
2 Hwang S, Yun H, Moon S, Cho YE, Gao B. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:751802. [PMID: 34707573 DOI: 10.3389/fendo.2021.751802] [Reference Citation Analysis]
3 Chen J, Lei S, Huang Y, Zha X, Gu L, Zhou D, Li J, Liu F, Li N, Du L, Huang X, Lin Z, Bu L, Qu S. The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery. Lipids Health Dis 2022;21:10. [PMID: 35034646 DOI: 10.1186/s12944-022-01622-0] [Reference Citation Analysis]
4 Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2021;22:2865. [PMID: 33799862 DOI: 10.3390/ijms22062865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Chung KW, Cho YE, Kim SJ, Hwang S. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis. Arch Pharm Res 2022. [PMID: 35391713 DOI: 10.1007/s12272-022-01379-1] [Reference Citation Analysis]